| Vitiligo |
0 |
1 |
| Adolescent Medicine |
0 |
0.99 |
| Child |
0 |
0.97 |
| Pediatric Dermatology |
0 |
0.29 |
| Dermatitis |
0 |
0.23 |
| COVID-19 |
0 |
0.2 |
| Washington |
0 |
0.14 |
| Face |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.08 |
| Skin Cancer |
0 |
0.06 |
| Atopic Dermatitis |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Immunocompromise |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Pandemic |
0 |
0.05 |
| Transplantation |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.04 |